SRC and breast cancer: Here, we explored the association between the various biomarkers implicated in Src signalling pathways and the in vitro response to dasatinib in 73 human cancer cell lines, including the current 34 ovarian cancer cell lines and 39 breast cancer cell lines that have been published earlier (Finn et al, 2007).